Huntsman Corporation vs Linde plc — Stock Comparison
Q·Score Breakdown
4.2
Bearish
Overall
7.2
Bullish
Quality
Health
Growth
Valuation
Sentiment
HUN
Healthy balance sheet and financial position.
⚠ elevated valuation at 76× forward P/E.
LIN
High-quality business with 18% return on equity and 20% profit margins.
⚠ valuation metrics above sector average.
Analyst Consensus
HOLD
Target $13.00 (-11.1%)
13 analysts
BUY
Target $526.89 (+3.7%)
25 analysts
Fundamentals
HUN
LIN
—
Trailing P/E
33.7×
75.9×
Forward P/E
25.8×
-5.8%
Profit Margin
20.4%
12.9%
Gross Margin
48.8%
-8.9%
ROE
18.2%
0.7%
Revenue Growth
8.2%
—
Earnings Growth
13.4%
—
Beta
0.79
—
Price / Book
—
$2.5B
Market Cap
$234.8B
$7 – $16
52-Week Range
$388 – $521
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →